SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-17-000020
Filing Date
2017-01-06
Accepted
2017-01-06 17:09:15
Documents
33
Period of Report
2016-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q immg_10q.htm 10-Q 140393
2 CERTIFICATION immg_ex311.htm EX-31.1 9040
3 CERTIFICATION immg_ex312.htm EX-31.2 9259
4 CERTIFICATION immg_ex321.htm EX-32.1 4054
5 CERTIFICATION immg_ex322.htm EX-32.2 3818
  Complete submission text file 0001640334-17-000020.txt   741250

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT immg-20161130.xml EX-101.INS 51160
7 XBRL TAXONOMY EXTENSION SCHEMA immg-20161130.xsd EX-101.SCH 13027
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE immg-20161130_cal.xml EX-101.CAL 15145
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE immg-20161130_def.xml EX-101.DEF 5537
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE immg-20161130_lab.xml EX-101.LAB 90308
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immg-20161130_pre.xml EX-101.PRE 58386
Mailing Address 10411 MOTOR CITY DR., SUITE 750 BETHESDA MD 20817
Business Address 10411 MOTOR CITY DR., SUITE 750 BETHESDA MD 20817 (480) 830-2700
IMMAGE BIOTHERAPEUTICS CORP. (Filer) CIK: 0001564273 (see all company filings)

IRS No.: 455538945 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 333-185368 | Film No.: 17515001
SIC: 2834 Pharmaceutical Preparations